Literature DB >> 33422222

Zinc and Coronavirus Disease 2019: Causal or Casual Association?

Alkesh Kumar Khurana1, Sunaina Tejpal Karna2, Aqeel Hussain3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33422222      PMCID: PMC7836617          DOI: 10.1016/j.chest.2020.08.2092

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
To the Editor: We read with interest the article by Yao et al this issue of CHEST whereby they have studied the effect of zinc supplementation in hospitalized patients of coronavirus disease 2019 (COVID-19) infection. In reference to the patient assessment parameters and results, one very important aspect needs attention. Although the authors have evaluated in detail the baseline clinical and treatment characteristics, they have no data pertaining to serum zinc levels before or after zinc supplementation. We do understand because this was a retrospective analysis with waiver of consent, but one should be cautious about the interpretation of results in this scenario. Before concluding that zinc supplementation did not lead to a statistically significant decrease in mortality or other outcome parameters, we should have data clarifying which patients were zinc deficient and which were not before receiving zinc supplementation. This could have been done by measuring serum zinc levels. It is well mentioned in literature that patients with certain respiratory illnesses, for example, asthma, have decreased serum zinc levels. Ibraheem et al recorded the prevalence of 98.3% for low serum zinc levels in children with acute lower respiratory tract infection than that in control subjects of 64.2%. Rerksuppaphol and Rerksuppaphol have also shown that zinc supplementation reduces the number of hospital days in children with acute lower respiratory tract infection, and their results were substantiated by measuring pre and post supplementation serum zinc levels. Serum zinc level is also the recommended modality to estimate dietary zinc status in individuals. Also, in COVID-19 disease, C-reactive protein has emerged as one of the key inflammatory markers, and serum zinc levels also have been found to be inversely proportional to C-reactive protein levels in some surveys. This further highlights the importance of getting serum zinc levels before making any conclusions about zinc therapy in such patients. The work done by the authors is worth appreciation; however, a prospective cohort study with pre and post zinc supplementation zinc levels would probably yield better or probably different answers.
  4 in total

1.  Serum zinc levels in hospitalized children with acute lower respiratory infections in the north-central region of Nigeria.

Authors:  Rasheedat Mobolaji Ibraheem; AbdulWahab Babatunde Rotimi Johnson; Aishatu Ahmed Abdulkarim; Sikiru A Biliaminu
Journal:  Afr Health Sci       Date:  2014-03       Impact factor: 0.927

2.  Adjusting plasma or serum zinc concentrations for inflammation: Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) project.

Authors:  Christine M McDonald; Parminder S Suchdev; Nancy F Krebs; Sonja Y Hess; K Ryan Wessells; Sanober Ismaily; Sabuktagin Rahman; Frank T Wieringa; Anne M Williams; Kenneth H Brown; Janet C King
Journal:  Am J Clin Nutr       Date:  2020-04-01       Impact factor: 7.045

3.  The Minimal Effect of Zinc on the Survival of Hospitalized Patients With COVID-19: An Observational Study.

Authors:  Jasper Seth Yao; Joseph Alexander Paguio; Edward Christopher Dee; Hanna Clementine Tan; Achintya Moulick; Carmelo Milazzo; Jerry Jurado; Nicolás Della Penna; Leo Anthony Celi
Journal:  Chest       Date:  2020-07-22       Impact factor: 9.410

4.  A randomized controlled trial of zinc supplementation in the treatment of acute respiratory tract infection in Thai children.

Authors:  Sanguansak Rerksuppaphol; Lakkana Rerksuppaphol
Journal:  Pediatr Rep       Date:  2019-05-23
  4 in total
  1 in total

1.  The Role of Diet and Supplementation of Natural Products in COVID-19 Prevention.

Authors:  Amin Gasmi; Salvatore Chirumbolo; Massimiliano Peana; Sadaf Noor; Alain Menzel; Maryam Dadar; Geir Bjørklund
Journal:  Biol Trace Elem Res       Date:  2021-02-25       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.